ESC 2024 - INTERASPIRE is a global registry study among patients with recent CHD across 6 WHO regions. Kausik Ray discusses Lp(a) levels in the INTERASPIRE cohort, and implications for risk factor control and ongoing and future clinical trials.
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
ESC 2024 - INTERASPIRE is a global registry study among patients with recent CHD across 6 WHO regions. Kausik Ray discusses Lp(a) levels in the INTERASPIRE cohort, and implications for risk factor control and ongoing and future clinical trials.
This video was recorded during the ESC Congress 2024 in London, UK.
Kausik Ray, MD is Professor of Public Health and Consultant Cardiologist at Imperial College London, UK.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 9 September 2024
ESC 2024 - INTERASPIRE is a global registry study among patients with recent CHD across 6 WHO regions. Kausik Ray discusses Lp(a) levels in the INTERASPIRE cohort, and implications for risk factor control and ongoing and future clinical trials.
This video was recorded during the ESC Congress 2024 in London, UK.
Kausik Ray, MD is Professor of Public Health and Consultant Cardiologist at Imperial College London, UK.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 9 September 2024
Stay current with the best on medical education
